
A Pharmaceutical Giant Surges: AbbVie’s Financial Spectacle Stuns Wall Street
AbbVie surpassed quarterly earnings expectations, driving a 3.10% stock increase, significantly outpacing the 0.6% rise of the S&P 500 index. Net revenues in Q1 reached $13.3 billion, reflecting an 8% increase, primarily driven by the success of Skyrizi and Rinvoq, which generated